Sign in Register

Correction: Broader factors associated with current adolescent overweight/obesity status in YRBSS 2023: Survey-aware analysis and calibrated AI-assisted classification

By The PLOS One Staff · · 1 min read

Save

There are errors in the author affiliations. The publisher apologizes for the errors.The correct affiliations are as follows: Thu Hoang Thanh 1 , Nhan Nguyen Thi 2 , Toan Nguyen Khac 3 1 University of Economics Ho Chi Minh City–UEH, Ho Chi Minh City, Vietnam, 2 Department of Midwifery, Faculty of Nursing and Medical Technology, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam, 3 Institute of Intelligent and Interactive Technologies, University of Economics Ho Chi Minh City, Vietnam.

Related articles

PubMed

Accuracy of the Final Growth Ultrasound in Predicting Birthweight Centile in Women With Class III Obesity: A Retrospective Cohort Study.

Introduction This study evaluated agreement between final third-trimester ultrasound estimated fetal weight (EFW) centile and subsequent birthweight centile in singleton pregnancies among women with class III obesity (body mass index (BMI) ≥40 kg/m²). Secondary objectives were to assess antenatal detection of small-for-gestational-age (SGA) and large-for-gestational-age (LGA) infants and associations of maternal BMI and scan-to-delivery interval with centile prediction error. Methods We condu...

PubMed

Effectiveness and Safety of Once-Weekly Semaglutide 2.4 mg in Korean Adults With Obesity or Overweight: A Multicenter Retrospective Real-World Study (RE-SEMA-K Study).

ABSTRACT Aims To evaluate the effectiveness and treatment patterns of once‐weekly semaglutide 2.4 mg in South Korean adults with overweight or obesity in real‐world practice. Materials and Methods This multicenter retrospective study analysed electronic medical records from 17 centres in South Korea. Included were adults (≥ 19 years) with BMI ≥ 25 kg/m2, or ≥ 23 kg/m2 with obesity‐related comorbidities. Primary endpoints were changes in body weight at 3, 6, 9, and 12 months. Secondary outcom...